When.com Web Search

  1. Ads

    related to: new medication for lupus treatment

Search results

  1. Results From The WOW.Com Content Network
  2. US FDA puts Kezar Life Sciences' lupus treatment trial on ...

    www.aol.com/news/us-fda-puts-kezar-life...

    Kezar was testing the drug in patients with active lupus nephritis, which causes inflammation and damage in the kidneys due to a form of immune-related condition called lupus.

  3. Anifrolumab - Wikipedia

    en.wikipedia.org/wiki/Anifrolumab

    Anifrolumab, sold under the brand name Saphnelo, is a monoclonal antibody used for the treatment of systemic lupus erythematosus. [5] [7] It binds to the type I interferon receptor, blocking the activity of type I interferons such as interferon-α and interferon-β.

  4. Biogen-UCB's lupus drug meets main goal of late-stage trial - AOL

    www.aol.com/news/biogen-ucbs-lupus-drug-meets...

    Biogen and Belgian partner UCB said on Tuesday their experimental lupus treatment met the main goal of a late-stage trial in patients with the chronic disease, a surprise result after the drug ...

  5. Voclosporin - Wikipedia

    en.wikipedia.org/wiki/Voclosporin

    Voclosporin, sold under the brand name Lupkynis, is a calcineurin inhibitor used as an immunosuppressant medication for the treatment of lupus nephritis. [2] [4] It is an analog of ciclosporin that has enhanced action against calcineurin and greater metabolic stability.

  6. Belimumab - Wikipedia

    en.wikipedia.org/wiki/Belimumab

    Belimumab is primarily used in people with systemic lupus erythematosus. When it was introduced in 2011, it was the first new drug approved to treat lupus in 56 years. [8] Sales rose to $31.2 million in the first quarter of 2012. [37] The total cost for the first year of treatment with belimumab is $28,000. [38]

  7. Roivant Sciences' lupus drug fails to reduce symptoms in mid ...

    www.aol.com/news/roivant-sciences-lupus-drug...

    The oral drug, brepocitinib, did not meet the primary study goal of reduction in disease activity at week 52 in patients of SLE, in which the immune system that normally helps protect the body ...

  1. Ads

    related to: new medication for lupus treatment